5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

被引：0
|
作者：
Kohno, Takeya [1 ]
Yamamoto, Manabu [1 ]
Tamachi, Tomoko [1 ]
Asai, Jyunji [1 ]
Oishi, Natsuko [1 ]
Ataka, Shinsuke [1 ]
Yasui, Ayako [1 ]
Cho, Akira [2 ]
Hirabayashi, Michiko [2 ]
Shiraki, Kunihiko [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Ophthalmol & Visual Sci, Osaka, Japan
[2] Shiraniwa Hosp, Ikoma, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
880
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Long-term Treatment Outcome of Intravitreal Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
    Kim, Ye Ji
    Han, Sang Yun
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2018, 59 (03): : 238 - 245
  • [22] Long-term prognosis of polypoidal choroidal vasculopathy with a 5-year remission after an initial combination therapy
    Kikushima, Wataru
    Sakurada, Yoichi
    Yoneyama, Seigo
    Sugiyama, Atsushi
    Matsubara, Mio
    Fukuda, Yoshiko
    Kashiwagi, Kenji
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [23] Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy
    Asano, Shotaro
    Azuma, Keiko
    Shimizu, Kimiko
    Yamamoto, Risako
    Lee, Jinhee
    Murata, Hiroshi
    Inoue, Tatsuya
    Asaoka, Ryo
    Obata, Ryo
    PLOS ONE, 2018, 13 (05):
  • [24] Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy
    Sakai, Tsutomu
    Okano, Kiichiro
    Kohno, Hideo
    Tsuneoka, Hiroshi
    ACTA OPHTHALMOLOGICA, 2016, 94 (08) : E765 - E771
  • [25] Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome
    M Ho
    E C F Lo
    A L Young
    D T L Liu
    Eye, 2014, 28 : 1469 - 1476
  • [26] INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY The Fujisan Study
    Gomi, Fumi
    Oshima, Yuji
    Mori, Ryusaburo
    Kano, Mariko
    Saito, Masaaki
    Yamashita, Ayana
    Iwata, Eiji
    Maruko, Ruka
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1569 - 1576
  • [27] Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome
    Ho, M.
    Lo, E. C. F.
    Young, A. L.
    Liu, D. T. L.
    EYE, 2014, 28 (12) : 1469 - 1476
  • [28] Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab
    Tan, C. S.
    Ngo, W. K.
    Lim, L. W.
    Lim, T. H.
    EYE, 2015, 29 (09) : 1238 - 1238
  • [29] Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
    Hikichi, Taiichi
    Kitamei, Hirokuni
    Shioya, Shoko
    BMC OPHTHALMOLOGY, 2016, 16
  • [30] Long-term Visual Outcome and Prognostic Factors After Intravitreal Ranibizumab Injections for Polypoidal Choroidal Vasculopathy
    Kang, Hae Min
    Koh, Hyoung Jun
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (04) : 652 - 660
12345